Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(10 sites)
United States
OSF Health Care, Peoria, Illinois University of Michigan Health Systems, Ann Arbor, Michigan Washington University School of Medicine, St Louis, Missouri Hackensack University Medical Center, Hackensack, New Jersey UT Southwestern Medical Center at Dallas, Dallas, Texas Virginia Cancer Specialists PC, Fairfax, Virginia